Skip links

Vyondys 53® (golodirsen)

Full Name Vyondys 53® (golodirsen)
Drug Vyondys 53
Manufacturer Sarepta Therapeutics, Inc.
Route of Administration Intravenous
Site of Care Home or Healthcare Facility
Approved Indication The treatment of Duchenne muscular dystrophy (DMD) in patients who have a confirmed mutation of the DMD gene that is amenable to exon 53 skipping
Disease Duchenne Muscular Dystrophy (DMD)
Therapeutic Area Neurology
Enrollment Form Link Vyondys 53 Enrollment Form
Phone Number 800-356-5034
Fax Number 877-339-4602
Product Website